Grade My Investments
Home › Free Stock Grades › ENOV

Enovis Corporation (ENOV) Stock Grade

ENOV · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$1.0B
P/E Ratio
—
Revenue Growth (YoY)
+6.7%
Net Margin
-52.7%
Return on Equity
—
Dividend Yield
None

About Enovis Corporation's fundamentals

Enovis Corporation is a small-cap medical device company with a market capitalization of $1.0 billion that achieved 6.7% year-over-year revenue growth. The company is currently unprofitable, reporting a net loss with a negative net margin of -52.7% in its latest annual statement. Despite accounting losses, Enovis generated positive free cash flow, suggesting the company is converting revenue into cash despite its bottom-line losses. The company does not pay a dividend.

Track ENOV free — no credit card required. Live grade + monthly AI report →